參考文獻(xiàn)/References:
[1] 中國(guó)健康促進(jìn)基金會(huì)肌少-骨質(zhì)疏松癥專(zhuān)家共識(shí)委員會(huì).肌少-骨質(zhì)疏松癥專(zhuān)家共識(shí)[J].中國(guó)骨質(zhì)疏松雜志,2022,28(11):1561-1570.
[2] NIELSEN B R,ANDERSEN H E,HADDOCK B,et al.Prevalence of muscle dysfunction concomitant with osteoporosis in a home-dwelling danish population aged 65-93 years-the copenhagen sarcopenia study[J].Exp Gerontol,2020,138:110974.
[3] 陳羽楠,林丹紅,陳立典.試析五體理論與中醫(yī)運(yùn)動(dòng)功能[J].中醫(yī)雜志,2018,59(4):276-280.
[4] 謝慶華,張昌攀,張豐毅,等.“肉為墻”理論在慢性筋骨病治療中的探討[J].風(fēng)濕病與關(guān)節(jié)炎,2022,11(10):56-59.
[5] 王國(guó)軍.“筋骨并重”理念在骨科疾病中的應(yīng)用[J].江蘇中醫(yī)藥,2019,51(11):41-44.
[6] 陳謙峰,靖媛,李書(shū)楠,等.基于整體觀念的皮部理論在局部望診中的應(yīng)用[J].中華中醫(yī)藥雜志,2021,36(11):6534-6536.
[7] 吳結(jié)枝,黃海平,陳沙,等.從“骨玄府-藏象”論骨質(zhì)疏松癥[J].中國(guó)骨質(zhì)疏松雜志,2022,28(8):1201-1204.
[8] 吳建軍,林賢燦,林適,等.肌酸在肌少-骨質(zhì)疏松癥中的應(yīng)用與研究進(jìn)展[J].中國(guó)骨質(zhì)疏松雜志,2023,29(7):998-1001.
[9] KIRK B,FEEHAN J,LOMBARDI G,et al.Muscle,bone,and fat crosstalk:the biological role of myokines,osteokines,and adipokines[J].Curr Osteoporos Rep,2020,18(4):388-400.
[10] 尹萌.《黃帝內(nèi)經(jīng)》五體理論及應(yīng)用研究[D].沈陽(yáng):遼寧中醫(yī)藥大學(xué),2023.
[11] 劉銳,伍娟娟.從“骨絡(luò)”探討骨質(zhì)疏松癥的病因病機(jī)[J].中醫(yī)研究,2010,23(1):11-12.
[12] 劉景峰,董寶強(qiáng),林星星,等.經(jīng)筋實(shí)質(zhì)探索——足陽(yáng)明經(jīng)筋型KOA患者結(jié)筋病灶點(diǎn)血流灌注量研究[J].遼寧中醫(yī)雜志,2018,45(10):2022-2026.
[13] 張峰,董寶強(qiáng),林星星,等.基于整體觀念的經(jīng)筋辨證體系構(gòu)建[J].中國(guó)針灸,2023,43(9):977-981.
[14] 耿春梅,陳奇剛,劉杏蓉,等.原發(fā)骨質(zhì)疏松癥痛點(diǎn)分布與經(jīng)筋理論相關(guān)性的臨床研究[J].四川中醫(yī),2022,40(2):186-190.
[15] 蔣夢(mèng)春,胡洲映,李雙蕾,等.基于“腎藏精生髓主骨”理論探討老年骨質(zhì)疏松癥與免疫系統(tǒng)的相關(guān)性[J].中醫(yī)藥學(xué)報(bào),2023,51(8):6-12.
[16] SONG J,LIU T,ZHAO J,et al.Causal associations of hand grip strength with bone mineral density and fracture risk:a mendelian randomization study[J].Front Endocrinol(Lausanne),2022,13:1020750.
[17] 秧榮昆,關(guān)智宇.基于腎主骨理論探討杜仲通過(guò)調(diào)控OPG/RANKL/RANK通路對(duì)去勢(shì)骨質(zhì)疏松大鼠的影響[J].中成藥,2023,45(1):70-74.
[18] LEE S S,KIM Y A,EUN B,et al.Betaine,a component of Lycium chinense,enhances muscular endurance of mice and myogenesis of myoblasts[J].Food Sci Nutr,2021,9(9):5083-5091.
[19] 黃展輝,魏其鵬,梁煒瑜,等.左歸丸通過(guò)FNDC5/Wnt3a/β-catenin通路治療絕經(jīng)后骨質(zhì)疏松癥的機(jī)制研究[J].中國(guó)骨質(zhì)疏松雜志,2023,29(8):1147-1153.
[20] LIU J,AN J,JIANG N,et al.Codonopsis pilosula polysaccharides promote osteogenic differentiation and inhibit lipogenic differentiation of rat bone marrow stem cells by activating β-catenin[J].Chem Biol Interact,2023,385:110721.
[21] FAN M,GU X,ZHANG W,et al.Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles[J].J Cachexia Sarcopenia Muscle,2022,13(6):2724-2739.
[22] 陳偉堅(jiān),姜濤,周宜,等.LC-MS聯(lián)合單細(xì)胞測(cè)序分析探討參苓白術(shù)散治療原發(fā)性骨質(zhì)疏松癥的作用機(jī)制[J].中國(guó)骨質(zhì)疏松雜志,2023,29(10):1458-1465.
[23] 鮑榮華,周虹,李旭云,等.補(bǔ)腎健脾方干預(yù)大鼠成骨細(xì)胞增殖和凋亡的實(shí)驗(yàn)研究[J].中國(guó)中醫(yī)骨傷科雜志,2021,29(10):9-12.
[24] 趙俊.補(bǔ)腎健脾方治療陽(yáng)虛型肌少癥的臨床研究[D].天津:天津中醫(yī)藥大學(xué),2020.
[25] 劉永霞,吳倫卉,張倩佳.熏洗結(jié)合蠟療法干預(yù)老年骨質(zhì)疏松患者腰背疼痛臨床研究[J].新中醫(yī),2017,49(7):136-138.
[26] 楊靜,陳鵬.經(jīng)筋推拿改善老年肌少癥患者下肢肌肉力量與質(zhì)量臨床觀察[J].浙江中醫(yī)雜志,2016,51(10):753.
[27] 張璟婷,薄化君,陳柯村.溫針灸腎俞穴治療絕經(jīng)后骨質(zhì)疏松癥的療效觀察[J].新疆醫(yī)科大學(xué)學(xué)報(bào),2023,46(7):961-965.
[28] 董云鵬,呂朝暉,李偉舉,等.劉軍教授治療肌少癥的學(xué)術(shù)經(jīng)驗(yàn)擷萃[J].按摩與康復(fù)醫(yī)學(xué),2023,14(12):29-31.
相似文獻(xiàn)/References:
[1]劉磊,萬(wàn)春友,全先輝,等.鎖定鋼板內(nèi)固定結(jié)合肱骨頭植骨重建治療
肱骨近端Neer三、四部分骨折[J].中醫(yī)正骨,2015,27(10):52.
[2]徐偉鋒,葉健,吳連國(guó).強(qiáng)骨飲對(duì)骨質(zhì)疏松性股骨頸骨折患者全髖關(guān)節(jié)置換術(shù)后
血清骨代謝生化指標(biāo)和骨密度的影響[J].中醫(yī)正骨,2015,27(02):12.
XU Weifeng,YE Jian,WU Lianguo.Effect of Qianggu Yin(強(qiáng)骨飲,QGY)on serum bone metabolism indexes and bone density after total hip arthroplasty in patients with osteoporotic femoral neck fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):12.
[3]龔江浩.股骨近端防旋髓內(nèi)釘聯(lián)合抗骨質(zhì)疏松藥物治療
不穩(wěn)定型老年股骨轉(zhuǎn)子間骨折的臨床觀察[J].中醫(yī)正骨,2015,27(04):29.
GONG Jianghao.A combination therapy of proximal femoral nail antirotation and anti-osteoporotic drugs for the treatment of unstable femoral intertrochanteric fractures in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):29.
[4]李冠慧,李燦東,李西海,等.雌激素調(diào)控絕經(jīng)后骨質(zhì)疏松癥骨吸收-骨形成
耦聯(lián)失衡的機(jī)制[J].中醫(yī)正骨,2016,28(02):36.
[5]費(fèi)國(guó)芳,費(fèi)紅良,王金法.兩種內(nèi)固定方法治療老年不穩(wěn)定性股骨轉(zhuǎn)子間骨折的對(duì)比研究[J].中醫(yī)正骨,2016,28(05):9.
FEI Guofang,FEI Hongliang,WANG Jinfa.Comparison of two kinds of internal fixation for treatment of unstable femoral intertrochanteric fractures in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(07):9.
[6]陳思凱,邢金明.骨水泥強(qiáng)化椎弓根螺釘內(nèi)固定治療老年胸腰椎壓縮性骨折[J].中醫(yī)正骨,2016,28(05):35.
[7]孫鵬,譚磊,閻乾,等.人工肱骨頭置換術(shù)治療老年肱骨近端Neer三、四部分骨折[J].中醫(yī)正骨,2016,28(05):43.
[8]王博,吳鵬,史曉林.強(qiáng)骨飲對(duì)去卵巢骨質(zhì)疏松大鼠骨顯微結(jié)構(gòu)的影響[J].中醫(yī)正骨,2016,28(07):6.
WANG Bo,WU Peng,SHI Xiaolin.A retrospective trial of postural reduction combined with percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(07):6.
[9]馮建軍,鄒浩,朱海燕,等.槲皮素對(duì)去卵巢大鼠血清骨鈣素和股骨Ⅰ型膠原蛋白水平的影響[J].中醫(yī)正骨,2016,28(07):10.
FENG Jianjun,ZOU Hao,ZHU Haiyan,et al.Leverage bone grafting and pedicle screw internal fixation through posterior approach for treatment of thoracolumbar fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(07):10.
[10]王吉利,萬(wàn)雷,張志海,等.抑制Dickkopf-1和Sclerostin表達(dá)對(duì)人成骨肉瘤細(xì)胞MG63骨代謝調(diào)節(jié)相關(guān)蛋白表達(dá)水平的影響[J].中醫(yī)正骨,2016,28(09):13.
WANG Jili,WAN Lei,ZHANG Zhihai,et al.Effect of suppression of Dickkopf-1 and Sclerostin expression on bone metabolism regulatory protein expression levels in human osteosarcoma MG63 cells[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(07):13.